Atherosclerotic Cardiovascular Disease (ASCVD) Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting atherosclerotic cardiovascular disease (ascvd) clinical trials across 29 countries. Studies span Phase 3, Not Applicable, Phase 4. Top locations include Beijing, China, Paris, France, Lille, France. Updated daily from ClinicalTrials.gov.


Atherosclerotic Cardiovascular Disease (ASCVD) Trials at a Glance

7 actively recruiting trials for atherosclerotic cardiovascular disease (ascvd) are listed on ClinicalTrialsFinder across 6 cities in 29 countries. The largest study group is Phase 3 with 3 trials, with the heaviest enrollment activity in Beijing, Paris, and Lille. Lead sponsors running atherosclerotic cardiovascular disease (ascvd) studies include Eli Lilly and Company, Hospital do Coracao, and Brigham and Women's Hospital.

Browse atherosclerotic cardiovascular disease (ascvd) trials by phase

Treatments under study

About Atherosclerotic Cardiovascular Disease (ASCVD) Clinical Trials

Looking for clinical trials for Atherosclerotic Cardiovascular Disease (ASCVD)? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Atherosclerotic Cardiovascular Disease (ASCVD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Atherosclerotic Cardiovascular Disease (ASCVD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 3

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals340 enrolled95 locationsNCT06813911
Recruiting
Phase 3

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Atherosclerotic Cardiovascular Disease (ASCVD)Elevated Lp(a)
Eli Lilly and Company10,450 enrolled752 locationsNCT07157774
Recruiting
Phase 4

Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

Atherosclerotic Cardiovascular Disease (ASCVD)Hypercholesterolemia
University Medical Centre Ljubljana60 enrolled1 locationNCT07581808
Recruiting

Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients

Cardiovascular DiseasesAtherosclerotic Cardiovascular Disease (ASCVD)Secondary Prevention
Peking University First Hospital5,448 enrolled1 locationNCT07542860
Recruiting
Not Applicable

Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)

Atherosclerotic Cardiovascular Disease (ASCVD)Familial Hypercholesterolemias
Nantes University Hospital600 enrolled9 locationsNCT06960902
Recruiting
Phase 3

Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease

Atherosclerotic Cardiovascular Disease (ASCVD)Atherothrombotic Diseases
Hospital do Coracao7,713 enrolled13 locationsNCT06930885
Recruiting

The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

Rheumatoid Arthritis (RA)Atherosclerotic Cardiovascular Disease (ASCVD)
Brigham and Women's Hospital120 enrolled1 locationNCT07315997